Search research articles
Contact Us
Filters
Showing results (11-20 of 88) with videos related to
Page
of 9
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
August 10, 2006
Increased estrogen sulfation of estradiol 17beta-D-glucuronide in metastatic tumor rat livers
Huadong Sun, Lichuan Liu, K Sandy Pang
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 30, 2012
Commentary: theoretical predictions of flow effects on intestinal and systemic availability in physiologically based pharmacokinetic intestine models: the traditional model, segregated flow model, and QGut model
K Sandy Pang, Edwin C Y Chow
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 10, 2023
Kirchhoff's Laws and Hepatic Clearance, Well-Stirred Model - Is There Common Ground?
Malcolm Rowland, Michael Weiss, K Sandy Pang
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 17, 2003
Influence of P-glycoprotein, transfer clearances, and drug binding on intestinal metabolism in Caco-2 cell monolayers or membrane preparations: a theoretical analysis
Debbie Tam, Huadong Sun, K Sandy Pang
Current Drug Metabolism
|
September 1, 2012
Why we need proper PBPK models to examine intestine and liver oral drug absorption
Edwin C Y Chow, K Sandy Pang
Biopharmaceutics & Drug Disposition
|
May 4, 2010
Interplay of transporters and enzymes in the Caco-2 cell monolayer: I. effect of altered apical secretion
Jianghong Fan, Han-Joo Maeng, K Sandy Pang
The Journal of Pharmacy and Pharmacology
|
September 25, 2008
Formed and preformed metabolites: facts and comparisons
K Sandy Pang, Marilyn E Morris, Huadong Sun
Pharmaceutics
|
April 5, 2020
The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug-Drug Interactions
K Sandy Pang, H Benson Peng, Keumhan Noh
Biopharmaceutics & Drug Disposition
|
December 16, 2016
Unequivocal evidence supporting the segregated flow intestinal model that discriminates intestine versus liver first-pass removal with PBPK modeling
K Sandy Pang, Qi Joy Yang, Keumhan Noh
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 6, 2021
In Defense of Current Concepts and Applications of Clearance in Drug Development and Therapeutics
Malcolm Rowland, Michael S Roberts, K Sandy Pang
Page
of 9
Search research articles
Search
Showing results (11-20 of 88) with videos related to
Sort By:
Page
of 9
The Journal of Pharmacology and Experimental Therapeutics
|
August 10, 2006
Increased estrogen sulfation of estradiol 17beta-D-glucuronide in metastatic tumor rat livers
Huadong Sun, Lichuan Liu, K Sandy Pang
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 30, 2012
Commentary: theoretical predictions of flow effects on intestinal and systemic availability in physiologically based pharmacokinetic intestine models: the traditional model, segregated flow model, and QGut model
K Sandy Pang, Edwin C Y Chow
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 10, 2023
Kirchhoff's Laws and Hepatic Clearance, Well-Stirred Model - Is There Common Ground?
Malcolm Rowland, Michael Weiss, K Sandy Pang
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 17, 2003
Influence of P-glycoprotein, transfer clearances, and drug binding on intestinal metabolism in Caco-2 cell monolayers or membrane preparations: a theoretical analysis
Debbie Tam, Huadong Sun, K Sandy Pang
Current Drug Metabolism
|
September 1, 2012
Why we need proper PBPK models to examine intestine and liver oral drug absorption
Edwin C Y Chow, K Sandy Pang
Biopharmaceutics & Drug Disposition
|
May 4, 2010
Interplay of transporters and enzymes in the Caco-2 cell monolayer: I. effect of altered apical secretion
Jianghong Fan, Han-Joo Maeng, K Sandy Pang
The Journal of Pharmacy and Pharmacology
|
September 25, 2008
Formed and preformed metabolites: facts and comparisons
K Sandy Pang, Marilyn E Morris, Huadong Sun
Pharmaceutics
|
April 5, 2020
The Segregated Intestinal Flow Model (SFM) for Drug Absorption and Drug Metabolism: Implications on Intestinal and Liver Metabolism and Drug-Drug Interactions
K Sandy Pang, H Benson Peng, Keumhan Noh
Biopharmaceutics & Drug Disposition
|
December 16, 2016
Unequivocal evidence supporting the segregated flow intestinal model that discriminates intestine versus liver first-pass removal with PBPK modeling
K Sandy Pang, Qi Joy Yang, Keumhan Noh
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 6, 2021
In Defense of Current Concepts and Applications of Clearance in Drug Development and Therapeutics
Malcolm Rowland, Michael S Roberts, K Sandy Pang
Page
of 9